News

"The horizon for FOP is bright."

Read more Share

Regeneron's OPTIMA Phase 3 Clinical Trial is Full

Read more Share

Do you have what it takes to be an Underpuppy? 

Read more Share

ICC Releases 3rd Edition of the FOP Treatment Guidelines

Read more Share

The I in IFOPA

Read more Share

"It Was Life-changing!"

Read more Share

Blueprint Medicines Study of BLU-782 Published in Science Translational Medicine

Read more Share

From Diagnosis to Fundraising

Read more Share

Regeneron Publishes Plain Language Summary of the LUMINA-1 Phase 2 Study in FOP

Read more Share

Andecaliximab Granted Orphan Drug Designation

Read more Share

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter